Tizanidine Hcl Tablet
Product Images NDC 80425-0023

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tizanidine Hcl (NDC 80425-0023). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Fig 1

Fig 1
This text provides dosing instructions for the medication tizanidine, with variations in dosage, administration with or without food, and different forms of the medication (tablets vs capsules). Additionally, the chart displays plasma tizanidine concentration in ng/mL over several hours after dosing.*
FDA Label Image

Fig 2

Fig 2
FDA Label Image

Fig 3

Fig 3
The text describes the improvement seen in the Ashworth score after treatment with Tizanidine. The mean dose used in the study was 26.8 mg. The table shows the scores at the end of titration, end of maintenance, and endpoint, across three weeks of the study.*
FDA Label Image

Structure

Structure
FDA Label Image

Tizanidine HCl 4mg Tab Qty 60 Ndc 80425 0023

Tizanidine HCl 4mg Tab Qty 60 Ndc 80425 0023
FDA Label Image

Tizanidine HCl 4mg Tab Qty 90 Ndc 80425 0023

Tizanidine HCl 4mg Tab Qty 90 Ndc 80425 0023
This text appears to be a label for a medication called Tizanidine HCL 4mg Tablet, packaged by "AdvancedRX". It is also noted that this medication can be compared to another called "ZOUFLEX". The label also has a code of "T000936".*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.